iBio, Inc. Market Cap

iBio, Inc. has a market cap or net worth of $49.43 million as of October 30, 2026. It is the 30,127th most valuable company in the world and the 4,615th biggest in the United States. Its market cap has increased by 63.15% in one year.

Market Cap

49.43M

Enterprise Value

-36.41M

1-Year Change

63.15%

Global Rank

#30,127

Country Rank

#4,615 United States

ChartMarket Cap Chart

Chart

Since November 16, 2009, iBio, Inc.'s market cap has increased from $27.70M to $49.43M, an increase of 78.46%. That is a compound annual growth rate of 3.47%.

Market Cap History

Date	Market Cap	% Change
Oct 30, 2026	49.50M	14.06%
Dec 31, 2025	43.40M	93.75%
Dec 31, 2024	22.40M	1,078.95%
Dec 29, 2023	1.90M	-52.50%
Dec 30, 2022	4.00M	-96.66%
Dec 31, 2021	119.70M	-37.40%
Dec 31, 2020	191.20M	2,320.25%
Dec 31, 2019	7.90M	-43.57%
Dec 31, 2018	14.00M	-14.63%
Dec 29, 2017	16.40M	-53.41%
Dec 30, 2016	35.20M	-18.71%
Dec 31, 2015	43.30M	-12.17%
Dec 31, 2014	49.30M	128.24%
Dec 31, 2013	21.60M	-27.03%
Dec 31, 2012	29.60M	10.04%
Dec 30, 2011	26.90M	-73.23%
Dec 31, 2010	100.50M	298.81%
Dec 31, 2009	25.20M	-9.03%
Nov 16, 2009	27.70M	-

View and export this data all the way back to 2009. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Connect Biopharma Holdings	50.52M
Hyperion DeFi	50.04M
Gain Therapeutics	49.32M
Serina Therapeutics	49.28M
Kalaris Therapeutics	48.32M
Annovis Bio	48.14M
Werewolf Therapeutics	47.92M
LeonaBio	46.54M

Market Cap Rankings